Latest News and Press Releases

The JAMA research found that digital health interventions supporting patient self-management improves primary care for patients with multiple chronic conditions.QHSLab supports medical decision making...

FDA-cleared and Easily Administered Skin Test for Environmental and Food Allergens; AllergiQT™ – Quick Test Targets Non-Allergy Specialists in Primary Care SettingsStrengthens USA Equities...

 ● Revenue Surpassed $1 million for Nine Months of 2021 Compared to $0 for the Same Period 2020 ● Gross Margin of 48% in Q3 Increased 290 Basis Points Versus Q2 2021 ● Issuance of 76,923 Shares...

Strengthening Business Model and Expanding Product Portfolio in Large Addressable End MarketQ-Scale Represents a Compelling and Reimbursable Value Proposition for USAQ’s Physician ClientsFurther...

Second Quarter 2021 Financial Results In-Line with July Pre-AnnouncementSuccessful $750,000 Capital Raise Increases Financial Flexibility to Execute on Growth StrategyAcquired AllergiEnd® Assets...

 ● Revenue Grew 50% to $456,219 Compared to Q1 2021 ● Gross Margin of 46% Increased 164 Basis Points Versus Q1 2021 ● Strengthening of Company Financial Position and Strategic Relationships West Palm...

●Acquisition Strengthens USAQ Business Model and Strategic Position●Purchase includes AllergiEnd® Method Patent, Trademark and Website●AllergiEnd®’s Product Portfolio Favorably Aligned with Industry...

-Further Expanding Independent Practitioner Network and Industry Visibility- West Palm Beach, FL, June 09, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on...

 ● Substantial Sequential Increase in Revenue and Gross Margin  ● Growth in Customer Base and Revenue Per Customer Compared to Q4 2020 ● Company Expects Sequential Increase in Gross Margin in Q2...

WEST PALM BEACH, FL, Feb. 17, 2021 (GLOBE NEWSWIRE) -- USA EQUITIES CORP. (OTCQB: USAQ) (the “Company,” “we,” or “our”) is focused on enabling primary care physicians (PCP’s) to increase their...